AI Wars: New OpenAI Tools Challenge DocuSign and HubSpot
OpenAI introduces two major new tools, "DocuGPT" and "Tailor Assist", directly challenging the core businesses of DocuSign and HubSpot, leading to market pressure on major software companies.
OpenAI introduces two major new tools, "DocuGPT" and "Tailor Assist", directly challenging the core businesses of DocuSign and HubSpot, leading to market pressure on major software companies.
Prediction platform Kalshi shattered trading records thanks to massive interest in football contracts, creating significant waves in the traditional sports betting market.
Lodging trends are negative. A sharp drop in international demand, especially in Europe, hurts Airbnb, Expedia, and Booking, according to Wedbush.
Robinhood Markets is exploring taking its fast-growing prediction markets product to countries like the UK and Europe, facing complex regulatory challenges as the industry blurs the lines between finance and gambling.
Pfizer becomes the first pharmaceutical company to announce a drug-pricing deal with the Trump administration, promising lower prices for up to 100 million patients and committing $70 billion to domestic R&D and manufacturing.
Skye Bioscience's promising, safe weight loss drug, nimacimab, earned a "Buy" rating and $20 price target from analysts.